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N-l3 ammonia mnmcs certain properties of micro-
spheres. It rapidly clears from blood into myocardium
where it becomes fixed in proportion to myocardial blood
flow. Used with positron emissiontomography as a means
for quantifying in vivo myocardial indicator concentra-
tions, N-13 ammonia may be useful for noninvasive de-
termination of myocardial blood flow with the arterial
reference sampling technique. This possibility was ex-
amined in 27 experiments in 10chronically instrumented
dogs at control, high and low blood flows. Myocardial
blood flow was calculated in vivo from the myocardial
N-13 tissue activity concentrations derived from serial
cross-sectional images of the heart, the 2 minute arterial
input function and the withdrawal rate of arterial blood.
Regional myocardial blood flow can be evaluated both in-
vasively and noninvasively. It is most accurately determined
with radioactive microspheres and the arterial reference
sampling technique (1,2). The procedure entails adminis-
tration of radioactive microspheres into the left atrium or
ventricle, withdrawal of arterial blood and measurement of
regional microsphere tissue concentrations in myocardium
by in vitro counting of tissue samples. The latter requirement
precludes use of this technique in human beings. However,
regional myocardial indicator tissue concentrations can now
be measured in vivo with positron emission computed to-
mography (3-7). Moreover, the positron-emitting blood flow
tracer, N-13 ammonia, exhibits properties that to some ex-
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These calculations were compared with blood flow de-
termined by the standard microsphere technique.
Blood flow determined in vivo with N·l3 ammonia
and positron emission tomography correlated with mi-
crosphere blood flow by Y=- 36.2 + I.53x - 0.0027x2
(r = 0.94 with a standard error of the estimate of 16
mllmin per 100 g). For flows from 44 to 200 ml/min per
100g, the relation between in vivoand in vitro measured
myocardial blood flow was nearly linear but reached a
plateau at flowshigher than 200 ml/min per 100g. These
results indicate that in dogs, blood flow in the physiologic
range can be quantified in vivo with N-13 ammonia and
positron emission tomography.
(1 Am Coli CardioI1985;5:92-100)
tent resemble those of radioactive microspheres (8,9). N-
13 ammonia is extracted and fixed in myocardium in pro-
portion to blood flow. However, its first capillary transit
extraction fraction is less than 100% and decreases further
with higher flows. The tracer clears rapidly from blood so
that the arterial input function is nearly complete within
minutes. Unlike radioactive microspheres, N-13 ammonia
is administered intravenously, so that use of this tracer in
combination with positron emission tomography would al-
low noninvasive measurements of regional myocardial blood
flow in human beings. It was, therefore, the purpose of our
study to examine in closed chest dogs the possibility of
employing the arterial reference sampling technique with
N-13 ammonia and positron emission tomography for mea-
suring regional myocardial blood flow in vivo.
Methods
Animal preparation. Ten mongrel dogs, weighing 20
to 30 kg (mean 25.2), were anesthetized with sodium pen-
tobarbital (25 rug/kg body weight), intubated and ventilated
with room air. Catheters were inserted into the carotid artery
and through the femoral artery into the abdominal aorta for
withdrawing arterial blood and monitoring systemic blood
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pressure. After a left thoracotomy, an electromagnetic flow
probe (series 500, Biotronics) was placed around the prox-
imal left circumflex coronary artery. Mechanical zero flow
was established during 10 second coronary occlusions with
a snare placed distally to the flow probe. A fine polyethylene
cannula was advanced through a puncture wound into the
left atrium and used for injection of radioactive micro-
spheres. AH catheters and wires were exteriorized to the
posterior aspect of the neck. The thoracic cavity was closed
and the chest wall was sutured. The dogs were allowed to
recover for 2 to 3 weeks.
Study protocol. The dog was anesthetized (sodium pen-
tobarbital, 25 mg/kg) and carefully positioned in the whole
body positron emission transaxial tomograph (ECAT II,
Ortec Inc., EG & G) (10) so that the long axis of the left
ventricle was perpendicular to the imaging plane. A "rec-
tilinear" transmission scan of the thorax of the dog was
used for centering the imaging plane through the mid left
ventricle. Transmission images were then recorded for sub-
sequent correction of photon attenuation.
A bolus of 20 mCi of N-13 ammonia contained in 2 to
8 ml of saline solution was injected intravenously while
single photon-emitting microspheres were administered into
the left atrium. The arterial input function for N-13 ammonia
was determined by withdrawing serial 30 second arterial
blood samples at a constant rate of 5 ml/min (Harvard Ap-
paratus Co.) over a 6 minute period. For microspheres, the
arterial input function was determined by withdrawal of
arterial blood from the abdominal aorta at a rate of 4.29
mllmin. Serial positron emission tomographic imaging be-
gan at the time of tracer injection and continued until five
I minute images were recorded.
A total of27 studies were performed in the 10 dogs. Ten
studies were performed in the control period, eight during
coronary hyperemia and nine after decreasing blood flow in
the circumflex artery territory. A I hour time interval be-
tween studies was allowed for physical decay of N-13 ac-
tivity (9.8 minute half-life). Myocardial blood flow was
increased with dipyridamole (Boehringer Ingelheim), in-
fused at a rate of 0.142 mg/min per kg body weight for 4
minutes (II). Regional myocardial blood flow was reduced
by constriction of the left circumflex coronary artery with
the hydraulic cuff. Changes in circumflex coronary flow
were monitored with the electromagnetic flow probe. Tracer
injection, blood sampling and serial tomographic imaging
were begun in the hyperemic experiments 4 minutes after
the end of the dipridamole infusion, and in the partial oc-
clusion experiments as soon as circumflex coronary artery
blood flow had stabilized at a lower level. The dog was
maintained in the same position during all experiments. This
was accomplished by drawing a line on the dog's chest along
the projection of the lower power neon laser beam of the
tomograph and keeping the laser beam aligned with the
demarcation line throughout the experiment.
After completion of the imaging studies, 10 em long
needles were pushed along the demarcation line through the
chest wall in the direction of the imaging plane into the
thorax and myocardium to identify the anatomic cross-
section of the heart that had been imaged by positron emis-
sion tomography. The dog was then killed with concentrated
potassium chloride solution, the chest cavity opened and
the heart removed. A I em thick cross-sectional slice of the
left ventricle along the needle insertion sites (that is, cor-
responding to the imaged cross section) was obtained and
photographed, and the wall thickness determined at six equally
spaced sites. The left ventricular cross section was then
divided into approximately I g samples. Each tissue sample
was weighed and transferred into counting tubes, and the
tissue microsphere activity concentrations determined by
well counting.
Measurement of regional myocardial blood flow with
radioactive microspheres. Regional myocardial blood flow
at the time of each N-13 ammonia injection was determined
with the microsphere technique (I). Carbonized polystyrene
microspheres (15 ± 5 /-L in diameter, suspended in 10%
dextran with I drop of Tween 80; 3M Company) were
resuspended with a vortex shaker and then by ultrasonifi-
cation. Approximately 2 x 106 microspheres labeled with
cobalt-57, tin-113, niobium-95, scandium-46 or ruthenium-
103 were injected. The activity in the blood and myocardial
tissue samples was measured in a sodium iodide (thallium)
well counter.
Regional myocardial bloodjlow (RMBF) was calculated
using equation I:
Fa' c,
RMBF = ----C;;-. 100 (ml/min per 100 g), (1)
where Fa is the withdrawal rate of arterial blood (ml/rnin),
Cm is the activity in the myocardial tissue sample (counts/min
per g) and C, is the total activity in the arterial blood sample
(counts/min) .
Positron emission tomographic imaging, data analysis
and calculation of blood flow with N-13 ammonia. N-13
ammonia was produced at the University of California at
Los Angeles Medical Cyclotron as described previously (8,9).
Serial positron tomographic imaging in the ungated, fixed
time mode was begun at the time of tracer injection and
continued until five serial I minute images were recorded.
The spatial resolution was 17 mm at full width-half maxi-
mum with a slice thickness of 19 mm. Because of a 20
second interval between the acquisition of each image, the
total imaging time amounted to 6.3 minutes. To evaluate
possible changes in tissue N-13 ammonia concentrations
over time, additional images were obtained in five studies
20 minutes after tracer injection.
Six regions of interest were assigned to the left ventric-
ular myocardium in each image. Their location corre-
sponded to those on the anatomic cross sections where re-
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gional wall thickness was determined. Each region of interest
was 0.84 crrr' in area (21 pixels). The counts per pixel were
then determined, averaged for the entire region of interest
and expressed as mean counts/pixel per min. Regional myo-
cardial blood flow was calculated by the arterial reference
sampling technique using equation 1. N-13 ammonia activ-
ity was measured by well counting.
The activity of the myocardial tissue sample (em) was
determined from the cross-sectional positron emission tom-
ographic images from myocardial regions of interest as de-
scribed earlier (7, 12,13) using equation 2:
Positron emission tomographic imaging and blood flow
measurements. Positron emission tomography yielded good
quality images of the myocardial distribution of N-13 am-
monia. Examples of serial images recorded at control, dur-
ing coronary hyperemia and during circumflex coronary ar-
tery constriction are shown in Figure I. The changes in
myocardial and blood N-13 activity concentrations after in-
travenous administration of N-13 ammonia in a control ex-
periment are shown in Figure 2. N-13 activity in the blood
is highest in the third sample (withdrawn 30 to 60 seconds
after injection). It rapidly declines thereafter and remains
relatively constant after 2.5 minutes.
Myocardial N-13 activity concentrations increase most
early after tracer injection and then stabilize (Table 1).
These changes were similar for all experiments and are
summarized for all studies in Figure 3. These time-
dependent N-13 activity concentrations were similar for the
control, hyperemic and partial occlusion experiments. Myo-
cardial N-13 activity concentrations increased most dra-
matically (by 13 to 29%) from the first (at 0.5 minute) to
the second measurement (at 1.83 minutes). For the next 4
minutes, myocardial N-13 activity concentrations increased
less rapidly. Interimagechanges in myocardial N-13 activity
concentrations were only small. In five studies with addi-
tional images at 20 minutes after N-13 ammonia adminis-
tration, regional N-13 activity concentrations were only 13
to 15% higher than those at 6.3 minutes.
Figure 1. Serial I minute cross-sectional images recorded at the
same level through the left ventricle at the control study (A), during
dipyridamole-induced hyperemia (8) and after constriction of the
left circumflex coronary artery (e). Homogeneous uptake of N-
13ammonia throughout the left ventricular myocardium is evident
in the control and hyperemic studies. The increase in myocardial
blood flow from control to hyperemia is reflected by higher N-13
activity concentrations. The images in C, obtained after partial left
circumflex coronary occlusion, show a marked reduction in tracer
concentration in the posterolateral wall of the myocardium (arrow).
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Results
Hemodynamic findings, In the 10 control experiments,
myocardial blood flow measured by microspheres averaged
99 ± 41 ml/min per 100 g. Mean arterial blood pressure
was 110 ± 18mrnHg and heartratewas 108 ± 24 beats/min.
In the eight hyperemic experiments, myocardial blood flow
increased to 169 ± 66 mllmin per 100 g, while arterial
blood pressure averaged 90 ± 20 mm Hg and heart rate
was 142 ± 20 beats/min. In the nine partial coronary oc-
clusion experiments, blood flow in the underperfused seg-
ment averaged 58 ± 28 mllmin per 100 g, while mean
arterial pressure and heart rate averaged 106 ± 16 mm Hg
and 1\8 ± 28 beats/min, respectively.
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In arterial blood, N-13 activity concentrations rapidly
increased after tracer administration, reached a maximum
in the second blood sample and then declined (Fig. 2).
Beginning with the fourth blood sample (90 to 120 seconds
Figure 2. Myocardial N-13 tissue concentrations determined from
serial positron emission tomographic images (A) and the arterial
blood N-13 ammonia concentrations derived from serial 30second
arterial blood samples (B)in a control experiment. In A, the width
of each bar represents the acquisition time of each serial image
and its height represents theN-13 activity concentration. In B, the
width of each bar corresponds to the 30 second blood sampling
time and its height to the N-13 activity concentration. Note the
increase inN-13 activity tissue concentrations as well as thehigher
blood activity concentrations in the first three samples. After 2
minutes, the activity remains relatively constant with most of the
N-13 activity bound to amino acids.
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after tracer injection), N-13 activity concentrations remained
low and without further significant changes over the next 4
minutes. Accordingly, the arterial input function was nearly
complete at the time of the second scan, that is, at 1.83
minutes after tracer injection. Myocardial blood flow was,
therefore, calculated from the myocardial N-13 activity tis-
sue concentrations derived from the second of the serial
tomographic images and the integral of the arterial N-13
concentrations to that time.
In vivo calculated regional myocardial blood flows in a
partial occlusion experiment are compared in Figure 4 with
regional myocardial blood flows by the in vitro microsphere
technique. Both measurements agree well, although the in
vivo method yields lower values than the in vitro micro-
sphere technique.
The two blood flow measurement techniques are com-
paredfor all dog experiments after averaging the tissue N-
13 concentrations in all six regions of interest in individual
experiments for the control and hyperemic studies. In the
partial occlusion experiments, the tissue concentrations
measured in vitro and in vivo in the low flow segment were
averaged. This usually involved two to three regions of
interest on the cross-sectional images and the corresponding
two to three tissue samples removed from the myocardial
slices. Figure 5 depicts the comparison of all 27 experi-
ments. The data are fitted best by a second order polynomial
regression equation. The segment of the regression curve
for the flow range from 44 to approximately 200 ml/min
per 100 g is relatively linear. Increases in microsphere blood
flow were associated with proportionate increases in the in
vivo calculated blood flows. At blood flows greater than
250 mllmin per 100 g. the regression curve stabilized as
further flow increases were associated with progressively
smaller increments in myocardial N-13 ammonia tissue
concentrations.
Effect of time on determination of blood flow. The
continuing though modest increase in myocardial N-13 ac-
tivity concentrations over the next three scans together with
the persistent though low concentration of N-13 activity in
the blood raised the possibility that in vivo calculated flows
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Table 1. Mean Myocardial N-13 Activity Concentrations ± I Standard Deviation and Their Changes OverTime in Each
Experimental Protocol
Partial Coronary Occlusion Studies
Scan Time (min) Control Studies (n = 10) Ischemic Zone (n = 9) Nonischemic Zone (n = 9)
Dipyridamole Hyperemia
Studies (n = 8)
I
2
3
4
5
0.50
1.83
3.17
4,50
5.83
20
11.886 ± 2,944(82%)
14,461 ± 3.679 (100%)
15,425 ± 4,122 (\06%)
16,123 ± 4,487 (111%)
16,680 ± 4,523 (115%)
17.542 ± 4.728 (121%)
(n = 3)
6.541 ± 1,854 (86%)
7,574 ± 3,321 (100%)
8,253 ± 2,643 (108o/c)
8,453 ± 2,491 (\ 11%)
8.678 ± 2,344 (114%)
11,945 ± 6,896 (87%)
13,772 ± 7,062 (100%)
15,021 ± 8,329 (109%)
15,888 ± 8,312 (\ 15%)
16,357 ± 8.297 (115%)
12,645 ± 3,899 (71%)*
17.707 ± 3,287 (100%)
18.724 ± 3,672 (106%)
19,716 ± 3,541 (111%)
20,016 ± 3,791 (113%)
20.540 ± 3,708 (116%)
(n = 2)
Time indicates the mid-point of each scan acquisition period for each consecutive scan. The numbers in parentheses indicate the percent changes
from scan 2, designated as lOOo/c. Intergroup comparisons reveal only insignificant differences between the progressive increases of myocardial N-13
activity concentrations with the exception of scan I of the dipyridamole hyperemia studies ("). Tissue concentration differences between each consecutive
scan were insignificant by analysis of variance but significant by Student's paired t test (except for difference between scans 4 and 5).
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Figure 3. Mean myocardial (MYOC) N-13 tissue concentrations
as a function of time in all 27 experiments. The rather large stan-
dard deviation is due to the fact that tissue concentrations were
averaged from all (control, hyperemic and low flow) experiments.
The myocardial N-13 tissue concentrations were obtained from
regions of interest assigned to the left ventricular myocardium and
are given for the time of the mid-point of each scan.
2 3 • 5
SCAN NUMBER
3.17, 4.50 and 5.83 minutes after tracer injection) and the
integral of the arterial N-13 ammonia concentrations to those
times.
Blood flows were also calculated from the myocardial
N-13 activity concentrations at 3.17,4.50 and 5.83 minutes
after tracer injection and the arterial input function integrated
only to 2.0 minutes. The rationale for the latter approach
was that the arterial input function was nearly complete and
residual activity in the blood represented primarily N-
13-labeled amino acids. Blood flows calculated by the first
approach decreased progressively and significantly with time
(Table 2, Fig. 4). Flows calculated from the 5.83 minutes
scan and the arterial input function to that time were 24.3
± 8% lower than those calculated at 1.83 minutes after
tracer injection. Conversely, flows calculated from the same
scan but using the integral of the arterial input function to
2.0 minutes were 13.3 ± 6.5% higherthan those calculated
at 1.83 minutes. Comparisons by Student's t test for paired
data disclosed the moderate changes in calculated flows to
be statistically significant from 1.83 to 4.5 minutes but not
from 4.5 to 5.83 minutes.
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depended on the time of measurement after tracer injection.
To examine such possible time-dependency, flows were cal-
culated from myocardial N-13 activity concentrations in
each of the third to fifth serial positron images (that is, at
Discussion
Current scintigraphic techniques such as thallium-201
imaging are useful for evaluating the relative distribution
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Figure 4. Comparison between in vivo and
in vitro measured regional blood flows in a
dog experiment with partial left circumflex
coronary artery occlusion. The upper panel
displays the imaged cross section (left) and
a schematic representation of the anatomic
cross section (right), both with the six cor-
responding regions of interest (ROI). The ef-
fect of the partial coronary occlusion on blood
flow in the posterolateral segment of the
myocardium is seen on the tomographic im-
age. In the lower left panel, the in vivo and
in vitro blood flows along the unrolled cross
section are compared and found to be similar,
although the in vivo measurements with N-
13 ammonia systematically underestimate the
microsphere regional myocardial blood flows
(RMBF). This is also seen in the lower right
panel where in vivo and in vitro blood flows
are compared. Both measurements correlate
well, while the slope of less than I indicates
a systematic underestimation of blood flow
by the in vivo technique.
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MYOCARDIAL BLOOD FLOW
Figure5. Relationbetweenregional myocardial blood
flow (MBF)determinedwiththe microspheretechnique
and with N-13 ammonia and positron emission to-
mography for all 27 experiments.
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Table 2. Effects of Time Interval Between N-13 Ammonia
Injection and Positron Emission Tomography Imaging on
Calculated Blood Flow Compared With Blood Flow Measured
From Scan 2
The table lists the average percent changes in blood flow calculated
from scan 2 and the integral of arterial N- I3 activity concentrations to that
time. Statistically significant differences between interscan changes are
indicated by * = P < 0.05 and t = p < 0.001. NS = not significant.
therefore, the distribution of myocardial blood flow at the
time of the injection (9). Finally, N-13 ammonia clears
rapidly from the blood. After intravenous injection, N-13
activity in blood declines within 2 minutes to approximately
5% of its peak value and in 5 minutes to about I to 2%
(8,21). Consequently, tracer recirculation and its effects on
tracer tissue concentrations should be small after the initial
2 minutes after tracer injection. The residual blood activity
thereafter represents N-13 bound primarily to amino acids
rather than N-13 ammonia (22). Their extraction by dog
myocardium is low (23,24).
Regional myocardial blood flow was calculated from the
arterial input function of N-13 ammonia from the time of
injection to 2 minutes and from the second of the serial
tomographic images acquired at 1.83 minutes (mid-point)
after tracer injection. The second scan was chosen because
myocardial N-13 ammonia uptake was still incomplete at
of blood flow in myocardium, but fail to provide quantitative
estimates in mllmin per 100g. As this study indicates, such
measurements may be possible with N-13 ammonia and
positron emission tomography. Previous studies with planar
imaging (15) or positron emission tomography (\6) dem-
onstrated the use of N-13 ammonia in human beings as a
tracer of blood flow for detecting coronary artery disease
and for assessing its extent. These earlier investigations were
largely qualitative. A more recent clinical study ( 16) allowed
estimates of absolute increases of blood flow from control
to dipyridamole-induced hyperemia, estimates that were based
on changes in N-13 ammonia tissue concentrations in human
myocardium and approximations of the arterial input func-
tion. The estimated increases were comparable with those
measured with coronary sinus thermistors by Brown et al.
(\ 7).
Relation between myocardial blood flow and N-B am-
monia tissue concentration. The rationale for use of N-
13 ammonia for determining in vivo regional myocardial
blood flow is based on the properties of this tracer which,
to some extent, resemble those of radioactive microspheres.
Myocardium accumulates and retains the tracer in propor-
tion to blood flow. However, the extraction fraction is less
than 100% and declines with higher flows. Accordingly,
the overall relation between blood flow and myocardial N-
13 ammonia tissue concentration is nonlinear. N-13 am-
monia becomes metabolically fixed in myocardium (9,18-20),
yet the trapping mechanism appears to be relatively insen-
sitive to changes in the hemodynamic and metabolic state
of the heart (9). Clearance of N-13 activity from myocar-
dium is slow. At the time of positron emission tomographic
imaging, the tracer distribution in myocardium reflects,
Scan no.
Time (min)
Input function
to 2.0 minutes
Input function
345
3.17 4.50 5.83
+6.7 ± 6.6%t + 10.6 ± 4.4%* + 13.3 ± 6.5% NS
-6.0 ± 5.7%t -17.4 ± 7.3%t -24.3 ± 8.0t
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Figure7. Relation between in vivo and in vitro calculated myo-
cardial blood flows (MBF) after correcting each individual data
point by the polynomial regression equation shown in Figure 5.
MYOCAIIDIAL BLOOD FLOW
300
in this experiment cannot account for the leveling off of
measured values at high flow rates. In the hyperemic ex-
periments, dipyridamole lowered peripheral resistance with
a compensatory increase in heart rate. Higher heart rates
result in an increase in mean myocardial wall thickness and,
hence, improve rather than worsen the retrieval of myo-
cardial activity from the cross-sectional images. The sta-
bilizing of in vivo measurements at higher levels is, as is
the case for most diffusible indicators, a function of the
flow-dependent decrease in the extraction fraction.
In vitro versus in vivo calculatedjiows. Using the regres-
sion equation describing the relation between in vitro and
in vivo calculated flows, the in vivo calculated flows can
be corrected. For example, applying this correction to our
data, in vivo calculated data correlated linearly with the in
vitro microsphere measurements (Fig. 7). The slope of the
regression line approaches unity, indicating that the correc-
tion yields values that are comparable with those calculated
by the in vitro technique. Although encouraging, there re-
mains considerable scatter of the data points about the
regressionline, with an average standarderror of 24 mllmin
per 100g. Moreover, the validity of this correction requires
further validation in a prospective manner.
The observed data scatter may be attributed to several
factors. Flow determined with particulate tracers such as
microspheres is known to differ from flow measured with
diffusible indicators (25). Also, the cross-sectional images
were recorded in an ungated mode. Wisenberg et al. (7),
demonstrated previously that indicator tissue concentrations
are determined more accurately from electrocardiographic
gatedratherthan from ungated images. Because of the longer
acquisition times required for gated image acquisition, the
use of gated image acquisition in this study was limited by
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Figure 6. Effects of the time interval between N-13 ammonia
administration and myocardial N-13 tissue concentration mea-
surements and arterial blood sampling on the in vivo calculation
of myocardial blood flow. Each of the bars in A show the mean
and I standard deviation for blood flow calculated from each of
the second to the fifth of the serial images and the arterial input
function to the time of each scan (B). Note thesignificant decline
in calculated values as compared with the values calculated from
each of the serial images and the arterial input function to only 2
minutes (A).
the time of the first scan. It increased by about 18% from
the first to the second scan, while subsequent increaseswere
only small and ranged from 2.3 to 7.3% between scans
acquired over the next 4 minutes. These increases were
similar in the hyperemic, control and low flow experiments.
The step-up in tissue concentrations from the first to the
second image with only minor subsequent increases implies
that the arterial input function for N-13 ammonia was nearly
complete at the time of the second image acquired 1.83
minutes after tracer injection.
Methodologic considerations. In vivo measurements of
myocardial blood flow systematically underestimated blood
flow determined by the microsphere technique. This is be-
cause N-13 ammonia is extracted less than 100% during a
singlecapillary transit. Over the flowrange from 40 to about
200 ml/min per 100 g, this relation is almost linear as in-
dicated by the linear regression equation for flows ranging
from 44 to 180 ml/min per 100 g of y = -7.4 + 0.94x,
a correlation coefficient of 0.92 and a standard error of the
estimate of 16 mllmin per 100 g. At higher blood flows,
the relation stabilizes. This plateau is most likely the result
of a declining "extraction fraction" for N-13 ammonia rather
than an artifactual decrease in count recovery. Altered wall
motion can cause artifactual changes in count recovery, but
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the relatively short physical half-life of N-13 ammonia.
Last, because of variations in the arterial input function, the
cut-off time at 2 minutes may not always accurately reflect
the true arterial input function and introduces additional
errors.
Low spatial resolution of the imaging device used in this
study. This is another potential source of error. It results
in substantial loss in recovered counts (approximately 30 to
50%) as a consequence of the partial volume effect. Ac-
cordingly, the factor required for correction of regional wall
thickness is large and likely to affect the accuracy of the
measurements. Discrepancies between average wall thick-
ness of the live beating heart and the wall thickness mea-
sured postmortem further reduce the accuracy. Inconsis-
tencies between the sites of in vivo tissue concentration and
of postmortem wall thickness measurements may further
contribute to the data scatter. These factors seem largely
responsible for variations in segmental tracer concentrations
between the various regions of interest along myocardial
cross-sectional images that averaged 9 ± 3% in the control
experiments. These variations prompted us to use the av-
erage instead of the regional flow values. Nevertheless,
regional measurements of blood flow are possible as indi-
cated in Figure 4. Many of these limitations can be overcome
with newer, high temporal and spatial resolution tomographs
that will reduce the magnitude of correction factors for par-
tial volume effect, permit measurements of segmental wall
thickness directly from the images and allow electrocardio-
graphic synchronized image acquisition.
Effects of time on measurements of blood flow. In
vivo measurements of blood flow with N-13 ammonia and
positron emission tomography are affected by the time of
measurement after tracer injection. Calculation of blood
flow from later scans (3.17 to 5.83 minutes) and the integral
of the arterial concentration to the time of image acquisition
yielded progressively lower values. Calculated flows at 5.83
minutes were 24.3 ± 8.0% lower than those calculated
from the second scan. Use of the arterial input function to
only 2 minutes for deriving blood flow from consecutive
scans reduced the magnitude of time-dependent changes.
For example, the calculated values from the third, fourth
and fifth scan, respectively, were only 6.7,10.6 and 13.3%
higher than those calculated from the 2 minute scans. Thus,
the latter approach reduces the effect of time dependency
on calculated flows.
Possible solutions to minimize the effects ()( time on cal-
culated blood flow are correction of values for the time
between tracer injection and imaging. For example, blood
flows calculated from the fifth scan could be corrected for
the 13.3% overestimation. This will be important when
myocardial blood flow is determined with this approach with
a single slice tomograph and the entire heart imaged by
recording serially contiguous cross-sectional images. With
the multislice capability of newer tornographs, several cross
sections could be acquired simultaneously, which would
obviate the need for serial imaging.
Clinical applications. In comparison with other more
complex techniques currently developed for measuring
myocardial blood flow like the rubidium-82 technique (26,27)
or the oxygen-IS water technique (28,29), the simplicity of
the current approach offers several advantages. The tech-
nique requires only one measurement of the myocardial N-
13 tissue concentration between 2 and 6 minutes after in-
travenous tracer injection, withdrawal of arterial blood for
2 minutes, well counter measurements of the arterial input
function and calibration of the positron emission tomograph
with the well counter.
Given the near linear relation between in vivo and in
vitro measurements within the low to moderately high flow
range, the N-13 ammonia/positron emission tomographic
technique will be sensitive for blood flow determinations in
patients at rest or during moderate hyperemia as well as in
patients with regional perfusion abnormalities. The utility
of this technique at higher flow ranges will largely depend
on the accuracy of regional tissue concentration measure-
ments with positron emission tomography. The shortcom-
ings with current instrumentation, as outlined earlier, rep-
resent a major limitation for the use of this approach to the
human heart in which in vivo determination of ventricular
wall thickness in exactly the imaged cross section may be
limited or impossible. The newer generation positron emis-
sion tomographs, however, offer far better temporal and
spatial resolutions so that rapid serial electrocardiographic
gated cross-sectional imaging will be possible and the loss
in count recovery considerably less. For correction of re-
sidual count recovery, direct measurements of regional wall
thickness may be possible directly from the cross-sectional
images. Finally, it may be possible to determine the arterial
input function directly from regions of interest assigned to
the left ventricular blood pool, thus obviating the need for
arterial blood sampling and rendering this approach largely
noninvasive.
The potential of N-13 ammonia for external quantifica-
tion of regional blood flow in human subjects has been
indicated in earlier studies (16). Application of this tech-
nique in human beings will require rigorous testing. The
optimal time for imaging and, hence. determination of seg-
mental tracer tissue concentrations will depend on the time
when the tracer has cleared almost completely from blood
and when the arterial input function as well as myocardial
tracer tissue uptake are completed. The possibility of using
positron emitting microspheres for measuring regional blood
flow with the arterial reference sampling technique and pos-
itron emission tomography (Selwyn et al., unpublished data)
would further allow validation of the N-13 ammonia tech-
nique against the microsphere technique as the standard.
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